Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease.

Alzheimer's disease (AD) is characterized by multiple, intertwined pathological features, including amyloid-β (Aβ) aggregation, metal ion dyshomeostasis, and oxidative stress. We report a novel compound (ML) prototype of a rationally designed molecule obtained by integrating structural elements for Aβ aggregation control, metal chelation, reactive oxygen species (ROS) regulation, and antioxidant activity within a single molecule. Chemical, biochemical, ion mobility mass spectrometric, and NMR studies indicate that the compound ML targets metal-free and metal-bound Aβ (metal-Aβ) species, suppresses Aβ aggregation in vitro, and diminishes toxicity induced by Aβ and metal-treated Aβ in living cells. Comparison of ML to its structural moieties (i.e., 4-(dimethylamino)phenol (DAP) and (8-aminoquinolin-2-yl)methanol (1)) for reactivity with Aβ and metal-Aβ suggests the synergy of incorporating structural components for both metal chelation and Aβ interaction. Moreover, ML is water-soluble and potentially brain permeable, as well as regulates the formation and presence of free radicals. Overall, we demonstrate that a rational structure-based design strategy can generate a small molecule that can target and modulate multiple factors, providing a new tool to uncover and address AD complexity.

[1]  B. Ruotolo,et al.  Reactivity of diphenylpropynone derivatives toward metal-associated amyloid-β species. , 2012, Inorganic chemistry.

[2]  D. Laurents,et al.  Alzheimer's Aβ40 Studied by NMR at Low pH Reveals That Sodium 4,4-Dimethyl-4-silapentane-1-sulfonate (DSS) Binds and Promotes β-Ball Oligomerization* , 2005, Journal of Biological Chemistry.

[3]  N. Kotov,et al.  Inhibition of amyloid peptide fibrillation by inorganic nanoparticles: functional similarities with proteins. , 2011, Angewandte Chemie.

[4]  K. Thalassinos,et al.  An investigation of the mobility separation of some peptide and protein ions using a new hybrid quadrupole/travelling wave IMS/oa-ToF instrument , 2007 .

[5]  Shaomin Li,et al.  Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.

[6]  F. Nicotra,et al.  Natural compounds against Alzheimer's disease: molecular recognition of Aβ1-42 peptide by Salvia sclareoides extract and its major component, rosmarinic acid, as investigated by NMR. , 2013, Chemistry, an Asian journal.

[7]  J. Hasserodt,et al.  Efficient synthesis and fluorescence properties of highly functionalized 2-aryl-quinazolin-4(3H)-ones , 2009 .

[8]  M. G. Savelieff,et al.  Untangling amyloid-β, tau, and metals in Alzheimer's disease. , 2013, ACS chemical biology.

[9]  Paul Edison,et al.  Drug repositioning for Alzheimer's disease , 2012, Nature Reviews Drug Discovery.

[10]  G. Bitan,et al.  Amyloid β-protein: Monomer structure and early aggregation states of Aβ42 and its Pro19 alloform , 2005 .

[11]  C. Orvig,et al.  Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease. , 2009, Chemical reviews.

[12]  C. Rice-Evans,et al.  Antioxidant activity applying an improved ABTS radical cation decolorization assay. , 1999, Free radical biology & medicine.

[13]  E. W. McDaniel,et al.  Transport Properties of Ions in Gases , 1988 .

[14]  P. Faller,et al.  Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide. , 2009, Dalton transactions.

[15]  B. Bahr,et al.  Z-Phe-Ala-diazomethylketone (PADK) Disrupts and Remodels Early Oligomer States of the Alzheimer Disease Aβ42 Protein* , 2012, The Journal of Biological Chemistry.

[16]  H. Jacobsen,et al.  Alzheimer's disease: from pathology to therapeutic approaches. , 2009, Angewandte Chemie.

[17]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[18]  C. Rice-Evans,et al.  Structure-antioxidant activity relationships of flavonoids and phenolic acids. , 1996, Free radical biology & medicine.

[19]  Peter Faller,et al.  Copper and Zinc Binding to Amyloid‐β: Coordination, Dynamics, Aggregation, Reactivity and Metal‐Ion Transfer , 2009, Chembiochem : a European journal of chemical biology.

[20]  P. Kollman,et al.  An approach to computing electrostatic charges for molecules , 1984 .

[21]  Lin Li,et al.  Chromatin immunoprecipitation: a tool for studying histone acetylation and transcription factor binding. , 2003, Methods.

[22]  B. Reif,et al.  Characterization of chemical exchange between soluble and aggregated states of beta-amyloid by solution-state NMR upon variation of salt conditions. , 2005, Biochemistry.

[23]  D. Teplow,et al.  Metabolism of the Swedish Amyloid Precursor Protein Variant in Neuro2a (N2a) Cells , 1996, The Journal of Biological Chemistry.

[24]  M. Lim,et al.  Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-β aggregation. , 2011, Metallomics : integrated biometal science.

[25]  R. Nanga,et al.  Design of small molecules that target metal-Aβ species and regulate metal-induced Aβ aggregation and neurotoxicity , 2010, Proceedings of the National Academy of Sciences.

[26]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[27]  K. P. Kepp,et al.  Bioinorganic chemistry of Alzheimer's disease. , 2012, Chemical reviews.

[28]  T. Wyttenbach,et al.  Design of a new electrospray ion mobility mass spectrometer , 2001 .

[29]  M. Kung,et al.  Novel stilbenes as probes for amyloid plaques. , 2001, Journal of the American Chemical Society.

[30]  Louise K. Charkoudian,et al.  A pro-chelator triggered by hydrogen peroxide inhibits iron-promoted hydroxyl radical formation. , 2006, Journal of the American Chemical Society.

[31]  Michael W. Beck,et al.  Tuning reactivity of diphenylpropynone derivatives with metal-associated amyloid-β species via structural modifications. , 2013, Inorganic chemistry.

[32]  H. Schugar,et al.  Combating Alzheimer's disease with multifunctional molecules designed for metal passivation. , 2007, Angewandte Chemie.

[33]  B. Havsteen,et al.  The biochemistry and medical significance of the flavonoids. , 2002, Pharmacology & therapeutics.

[34]  Alaina S. DeToma,et al.  Myricetin: A Naturally Occurring Regulator of Metal‐Induced Amyloid‐β Aggregation and Neurotoxicity , 2011, Chembiochem : a European journal of chemical biology.

[35]  S. Sensi,et al.  Alzheimer's disease, metal ions and metal homeostatic therapy. , 2009, TIPS - Trends in Pharmacological Sciences.

[36]  Shirley Y. Lee,et al.  A partially folded structure of amyloid-beta(1-40) in an aqueous environment. , 2011, Biochemical and biophysical research communications.

[37]  J. Brender,et al.  Association of highly compact type II diabetes related islet amyloid polypeptide intermediate species at physiological temperature revealed by diffusion NMR spectroscopy. , 2009, Journal of the American Chemical Society.

[38]  C. Robinson,et al.  Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease. , 2009, Nature chemistry.

[39]  C. Rodríguez-Rodríguez,et al.  The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases , 2012 .

[40]  M. Lim,et al.  Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited. , 2009, Inorganic chemistry.

[41]  M. Telpoukhovskaia,et al.  Werner coordination chemistry and neurodegeneration. , 2013, Chemical Society reviews.

[42]  G. Bitan,et al.  Aβ(39-42) modulates Aβ oligomerization but not fibril formation. , 2012, Biochemistry.

[43]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[44]  Johann Gasteiger,et al.  A new model for calculating atomic charges in molecules , 1978 .

[45]  A. Ramamoorthy,et al.  Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-β species. , 2011, Inorganic chemistry.

[46]  J. Brender,et al.  Insights into antiamyloidogenic properties of the green tea extract (−)-epigallocatechin-3-gallate toward metal-associated amyloid-β species , 2013, Proceedings of the National Academy of Sciences.

[47]  Ayyalusamy Ramamoorthy,et al.  Misfolded proteins in Alzheimer's disease and type II diabetes. , 2012, Chemical Society reviews.

[48]  A. Ramamoorthy,et al.  Small molecule modulators of copper-induced Abeta aggregation. , 2009, Journal of the American Chemical Society.

[49]  J. Gasteiger,et al.  ITERATIVE PARTIAL EQUALIZATION OF ORBITAL ELECTRONEGATIVITY – A RAPID ACCESS TO ATOMIC CHARGES , 1980 .

[50]  M. Lim,et al.  Metal-associated amyloid-β species in Alzheimer's disease. , 2012, Current opinion in chemical biology.

[51]  A. Naito,et al.  NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG. , 2012, Journal of molecular biology.

[52]  J. Brewer,et al.  Solution NMR Studies of the Aβ(1−40) and Aβ(1−42) Peptides Establish that the Met35 Oxidation State Affects the Mechanism of Amyloid Formation , 2004 .

[53]  I. Hamley.  The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. , 2012, Chemical reviews.

[54]  P. Gans,et al.  Hyperquad simulation and speciation (HySS): a utility program for the investigation of equilibria involving soluble and partially soluble species , 1999 .

[55]  R. Nussinov,et al.  Polymorphism in Alzheimer Aβ Amyloid Organization Reflects Conformational Selection in a Rugged Energy Landscape , 2010, Chemical reviews.

[56]  A. Bush,et al.  Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics , 2010, Progress in Neurobiology.

[57]  M. Bowers,et al.  Structural motifs of DNA complexes in the gas phase , 2005 .

[58]  M. Gallagher,et al.  A specific amyloid-β protein assembly in the brain impairs memory , 2006, Nature.

[59]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .

[60]  P. K. Glasoe,et al.  USE OF GLASS ELECTRODES TO MEASURE ACIDITIES IN DEUTERIUM OXIDE1,2 , 1960 .

[61]  Mu-Hyun Baik,et al.  Direct nitric oxide detection in aqueous solution by copper(II) fluorescein complexes. , 2006, Journal of the American Chemical Society.

[62]  Edward A. Mason,et al.  Transport Properties of Ions in Gases: MASON:TRANSPORT PROPERTIES O-BK , 2005 .

[63]  Li Di,et al.  PAMPA--critical factors for better predictions of absorption. , 2007, Journal of pharmaceutical sciences.

[64]  Dylan W Domaille,et al.  Metals in neurobiology: probing their chemistry and biology with molecular imaging. , 2008, Chemical reviews.

[65]  Nicolas L. Fawzi,et al.  Kinetics of amyloid beta monomer-to-oligomer exchange by NMR relaxation. , 2010, Journal of the American Chemical Society.

[66]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[67]  B. Meyer,et al.  Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. , 2001, Journal of the American Chemical Society.

[68]  Li Di,et al.  High throughput artificial membrane permeability assay for blood-brain barrier. , 2003, European journal of medicinal chemistry.

[69]  Paul Schanda,et al.  Very fast two-dimensional NMR spectroscopy for real-time investigation of dynamic events in proteins on the time scale of seconds. , 2005, Journal of the American Chemical Society.